Related references
Note: Only part of the references are listed.Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in CIpP: A Model for the CIpX/CIpA-Bound State of CIpP
Dominic Him Shun Li et al.
CHEMISTRY & BIOLOGY (2010)
Structurally Refined β-Lactones as Potent Inhibitors of Devastating Bacterial Virulence Factors
Thomas Boettcher et al.
CHEMBIOCHEM (2009)
Staphylococcus aureus ClpC ATPase is a late growth phase effector of metabolism and persistence
Indranil Chatterjee et al.
PROTEOMICS (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
beta-lactones as privileged structures for the active-site labeling of versatile bacterial
Thomas Boettcher et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Mycobacterium tuberculosis ClpC1
Narayani P. Kar et al.
FEBS JOURNAL (2008)
In vivo inactivation of the mycobacterial integral membrane stearoyl coenzyme a desaturase DesA3 by a C-terminus-specific degradation process
Yong Chang et al.
JOURNAL OF BACTERIOLOGY (2008)
Confronting the scientific obstacles to global control of tuberculosis
Douglas B. Young et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria
Dorte Frees et al.
MOLECULAR MICROBIOLOGY (2007)
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
H Brötz-Oesterhelt et al.
NATURE MEDICINE (2005)
AAA+ proteins: Have engine, will work
PI Hanson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
Tetracycline-inducible gene regulation in mycobacteria
MCJ Blokpoel et al.
NUCLEIC ACIDS RESEARCH (2005)
Prospects for new antitubercular drugs
K Duncan et al.
CURRENT OPINION IN MICROBIOLOGY (2004)
Sculpting the proteome with AAA+ proteases and disassembly machines
RT Sauer et al.
CELL (2004)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
Share Paper
